Also, MLH1/PMS2 loss is associated with a low tumor mutational burden, which is also a negative prognostic factor.22 Other studies evaluating the prognostic value of individual MMR proteins or MMR protein subtypes are limited; therefore, additional studies are needed to verify our findings. This evidence concerns the gene PMS2 and neoplasm.